These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17474247)

  • 1. Role of p53 and bcl2 as markers of vitamin A response in premalignant lesions of the oral cavity.
    Varma D; Gupta S; Mandal AK
    Indian J Pathol Microbiol; 2007 Jan; 50(1):15-7. PubMed ID: 17474247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
    Shin DM; Xu XC; Lippman SM; Lee JJ; Lee JS; Batsakis JG; Ro JY; Martin JW; Hittelman WN; Lotan R; Hong WK
    Clin Cancer Res; 1997 Jun; 3(6):875-80. PubMed ID: 9815762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 aberrations in oral sub mucous fibrosis and oral cancer detected by immunohistochemistry.
    Bathi RJ; Prabhat
    Indian J Dent Res; 2003; 14(4):214-9. PubMed ID: 15328987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.
    Ralhan R; Nath N; Agarwal S; Mathur M; Wasylyk B; Shukla NK
    Clin Cancer Res; 1998 Sep; 4(9):2147-52. PubMed ID: 9748133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
    Mallick S; Patil R; Gyanchandani R; Pawar S; Palve V; Kannan S; Pathak KA; Choudhary M; Teni TR
    J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters.
    Raju B; Mehrotra R; Oijordsbakken G; Al-Sharabi AK; Vasstrand EN; Ibrahim SO
    Anticancer Res; 2005; 25(6C):4699-706. PubMed ID: 16334163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c.
    Kyndi M; Sørensen FB; Knudsen H; Alsner J; Overgaard M; Nielsen HM; Overgaard J
    Acta Oncol; 2008; 47(4):608-17. PubMed ID: 18465329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valuation of exfoliative cytology as prediction factor in oral mucosa lesions.
    Brunotto M; Zárate AM; Cismondi A; Fernández Mdel C; Noher de Halac RI
    Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E92-102. PubMed ID: 15995578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka.
    Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y
    J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa.
    Ogden GR; Kiddie RA; Lunny DP; Lane DP
    J Pathol; 1992 Apr; 166(4):389-94. PubMed ID: 1381431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission of oral precancerous lesions of tobacco/areca nut chewers following administration of beta-carotene or vitamin A, and maintenance of the protective effect.
    Stich HF; Mathew B; Sankaranarayanan R; Nair MK
    Cancer Detect Prev; 1991; 15(2):93-8. PubMed ID: 2032261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
    de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
    Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 expression in oral cancer: observations of a South Indian study.
    Pillay M; Vasudevan DM; Rao CP; Vidya M
    J Exp Clin Cancer Res; 2003 Sep; 22(3):447-51. PubMed ID: 14582705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesions.
    Wirth LJ; Krane JF; Li Y; Othus M; Moran AE; Dorfman DM; Norris CM; Goguen L; Posner MR; Haddad RI; Bertagnolli MM
    Cancer Prev Res (Phila); 2008 Oct; 1(5):339-48. PubMed ID: 19138978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
    Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India.
    Teni T; Pawar S; Sanghvi V; Saranath D
    Pathol Oncol Res; 2002; 8(2):109-14. PubMed ID: 12172574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.
    Marx A; Wandrey T; Simon P; Wewer A; Grob T; Reichelt U; Minner S; Simon R; Spehlmann M; Tigges W; Soehendra N; Seitz U; Seewald S; Izbicki JR; Yekebas E; Kaifi JT; Mirlacher M; Terracciano L; Fleischmann A; Raedler A; Sauter G
    Hum Pathol; 2009 Feb; 40(2):166-73. PubMed ID: 18835622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67.
    Acay RR; Felizzola CR; de Araújo N; de Sousa SO
    Oral Oncol; 2006 May; 42(5):475-80. PubMed ID: 16364678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.